- Home
- INTS vs INBS Comparison
INTS vs INBS Comparison
Compare INTS & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- INBS
- Stock Information
- Founded
- INTS 2012
- INBS 2016
- Country
- INTS United States
- INBS United States
- Employees
- INTS N/A
- INBS N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- INBS Medical Specialities
- Sector
- INTS Health Care
- INBS Health Care
- Exchange
- INTS Nasdaq
- INBS Nasdaq
- Market Cap
- INTS 10.9M
- INBS 11.7M
- IPO Year
- INTS 2023
- INBS N/A
- Fundamental
- Price
- INTS $0.23
- INBS $1.79
- Analyst Decision
- INTS Strong Buy
- INBS
- Analyst Count
- INTS 4
- INBS 0
- Target Price
- INTS $4.50
- INBS N/A
- AVG Volume (30 Days)
- INTS 4.0M
- INBS 127.5K
- Earning Date
- INTS 11-12-2025
- INBS 11-06-2025
- Dividend Yield
- INTS N/A
- INBS N/A
- EPS Growth
- INTS N/A
- INBS N/A
- EPS
- INTS N/A
- INBS N/A
- Revenue
- INTS N/A
- INBS $3,052,532.00
- Revenue This Year
- INTS N/A
- INBS $778.48
- Revenue Next Year
- INTS N/A
- INBS N/A
- P/E Ratio
- INTS N/A
- INBS N/A
- Revenue Growth
- INTS N/A
- INBS N/A
- 52 Week Low
- INTS $0.19
- INBS $1.10
- 52 Week High
- INTS $4.30
- INBS $2.75
- Technical
- Relative Strength Index (RSI)
- INTS 32.86
- INBS 62.21
- Support Level
- INTS $0.27
- INBS $1.65
- Resistance Level
- INTS $0.30
- INBS $1.78
- Average True Range (ATR)
- INTS 0.02
- INBS 0.11
- MACD
- INTS -0.00
- INBS 0.03
- Stochastic Oscillator
- INTS 6.39
- INBS 92.86
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).